Melanoma‐associated glycosyltransferase GCNT2 as an emerging biomarker and therapeutic target*-Reference-Cited by-同舟云学术

Melanoma‐associated glycosyltransferase GCNT2 as an emerging biomarker and therapeutic target*

Published:2021-05-04 Issue:2 Volume:185 Page:294-301
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br J Dermatol

Author:

Perez M.¹,Chakraborty A.¹,Lau L.S.¹,Mohammed N.B.B.¹,Dimitroff C.J.¹^ORCID

Affiliation:

1. Department of Translational Medicine Translational Glycobiology Institute at FIU Herbert Wertheim College of Medicine Florida International University Miami FL USA

Funder

National Cancer Institute

National Institute of Allergy and Infectious Diseases

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjd.19891

Reference75 articles.

1. Patterns of failure after immunotherapy with checkpoint inhibitors predict durable progression-free survival after local therapy for metastatic melanoma

2. Novel MITF targets identified using a two-step DNA microarray strategy

3. N-Glycosylation in progression of skin cancer

4. ST6Gal-I sialyltransferase promotes chemoresistance in pancreatic ductal adenocarcinoma by abrogating gemcitabine-mediated DNA damage

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insights into the role of glycosyltransferase in the targeted treatment of gastric cancer;Biomedicine & Pharmacotherapy;2024-09

2. Chemicals and Small Molecules for Iris Color Modification;Quest for Eye Color Modification;2024

3. Advances in adoptive T-cell therapy for metastatic melanoma;Current Research in Translational Medicine;2023-07

4. Hypoxia Controls the Glycome Signature and Galectin-8–Ligand Axis to Promote Protumorigenic Properties of Metastatic Melanoma;Journal of Investigative Dermatology;2023-03

5. Total serum N-glycans associate with response to immune checkpoint inhibition therapy and survival in patients with advanced melanoma;BMC Cancer;2023-02-18